RxSight (NASDAQ:RXST) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.25) by 100.4 percent. This is a 100.53 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $35.31 million which beat the analyst consensus estimate of $35.06 million by 0.72 percent. This is a 59.08 percent increase over sales of $22.20 million the same period last year.